• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A case of Hodgkin's lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD.1例肝功能严重受损的霍奇金淋巴瘤患者,接受吉西他滨治疗后再行ABVD方案治疗,获得成功。
J Blood Med. 2015 Mar 23;6:93-7. doi: 10.2147/JBM.S67664. eCollection 2015.
2
Spermatogenesis in Hodgkin's lymphoma patients: a retrospective study of semen quality before and after different chemotherapy regimens.霍奇金淋巴瘤患者的精子发生:不同化疗方案前后精液质量的回顾性研究
Hum Reprod. 2016 Feb;31(2):263-72. doi: 10.1093/humrep/dev310. Epub 2015 Dec 23.
3
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.ABVD 方案中省略达卡巴嗪或博来霉素或两者在治疗早期有利霍奇金淋巴瘤(GHSG HD13)中的应用:一项开放标签、随机、非劣效性试验。
Lancet. 2015 Apr 11;385(9976):1418-27. doi: 10.1016/S0140-6736(14)61469-0. Epub 2014 Dec 22.
4
Comparison between hybrid MOPPABV and ABVD chemotherapy protocols for Hodgkin's lymphoma in public hospitals of the largest South American city: a retrospective 14-year study.南美最大城市公立医院中霍奇金淋巴瘤的混合MOPPABV与ABVD化疗方案比较:一项为期14年的回顾性研究
Ann Hematol. 2009 Jul;88(7):633-7. doi: 10.1007/s00277-008-0635-0. Epub 2008 Nov 8.
5
Brentuximab vedotin combined with ABVD or AVD for patients with newly diagnosed Hodgkin's lymphoma: a phase 1, open-label, dose-escalation study.本妥昔单抗维迪昔联合 ABVD 或 AVD 方案用于治疗初诊霍奇金淋巴瘤患者的 1 期、开放标签、剂量递增研究。
Lancet Oncol. 2013 Dec;14(13):1348-56. doi: 10.1016/S1470-2045(13)70501-1. Epub 2013 Nov 15.
6
Rapidly alternating COPP/ABV/IMEP is not superior to conventional alternating COPP/ABVD in combination with extended-field radiotherapy in intermediate-stage Hodgkin's lymphoma: final results of the German Hodgkin's Lymphoma Study Group Trial HD5.在中期霍奇金淋巴瘤中,快速交替使用COPP/ABV/IMEP方案并不优于传统交替使用COPP/ABVD方案联合扩大野放疗:德国霍奇金淋巴瘤研究组HD5试验的最终结果
J Clin Oncol. 2002 Jan 15;20(2):476-84. doi: 10.1200/JCO.2002.20.2.476.
7
Relapse and late complications in early-stage Hodgkin's disease patients with mediastinal involvement treated with radiotherapy alone or plus one cycle of ABVD.仅接受放疗或接受放疗加一个周期ABVD方案治疗的伴有纵隔受累的早期霍奇金病患者的复发及晚期并发症
Haematologica. 1999 Oct;84(10):917-23.
8
Neutropenia and febrile neutropenia in patients with Hodgkin's lymphoma treated with doxorubicin (Adriamycin), bleomycin, vinblastine and dacarbazine (ABVD) chemotherapy.接受阿霉素(多柔比星)、博来霉素、长春花碱和达卡巴嗪(ABVD)化疗的霍奇金淋巴瘤患者的中性粒细胞减少症和发热性中性粒细胞减少症。
Leuk Lymphoma. 2006 Apr;47(4):657-63. doi: 10.1080/10428190500353430.
9
Results of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine and highly active antiretroviral therapy in advanced stage, human immunodeficiency virus-related Hodgkin's lymphoma.多柔比星、博来霉素、长春碱和达卡巴嗪治疗与高效抗逆转录病毒疗法用于晚期人类免疫缺陷病毒相关霍奇金淋巴瘤的结果。
Haematologica. 2007 Feb;92(2):191-8. doi: 10.3324/haematol.10479.
10
Treatment of stage I and II Hodgkin's lymphoma with ABVD chemotherapy: results after 7 years of a prospective study.采用ABVD化疗方案治疗Ⅰ期和Ⅱ期霍奇金淋巴瘤:一项前瞻性研究7年后的结果
Ann Oncol. 2004 Dec;15(12):1798-804. doi: 10.1093/annonc/mdh465.

引用本文的文献

1
Extracellular Vesicle miR-122-5p as a Prognostic Biomarker in Pediatric Classical Hodgkin Lymphoma.细胞外囊泡miR-122-5p作为儿童经典型霍奇金淋巴瘤的预后生物标志物
Int J Mol Sci. 2024 Dec 10;25(24):13243. doi: 10.3390/ijms252413243.
2
Targeting lysophosphatidic acid receptor with Ki16425 impedes T cell lymphoma progression through apoptosis induction, glycolysis inhibition, and activation of antitumor immune response.用Ki16425靶向溶血磷脂酸受体可通过诱导凋亡、抑制糖酵解和激活抗肿瘤免疫反应来阻碍T细胞淋巴瘤的进展。
Apoptosis. 2022 Jun;27(5-6):382-400. doi: 10.1007/s10495-022-01723-2. Epub 2022 Apr 2.

本文引用的文献

1
Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant.对于既往自体移植后复发的霍奇金淋巴瘤患者,基于含吉西他滨的挽救性化疗的治疗策略,旨在进行第二次干细胞移植。
Leuk Lymphoma. 2013 May;54(5):973-8. doi: 10.3109/10428194.2012.734612. Epub 2012 Oct 29.
2
Efficacy and safety of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed/refractory lymphoma: a prospective multi-center phase II study by the Puget Sound Oncology Consortium.吉西他滨、卡铂、地塞米松和利妥昔单抗治疗复发/难治性淋巴瘤患者的疗效和安全性:一项由普吉特海湾肿瘤学联盟进行的前瞻性多中心 II 期研究。
Leuk Lymphoma. 2010 Aug;51(8):1523-9. doi: 10.3109/10428194.2010.491137.
3
Hodgkin lymphoma and fulminant hepatic failure.
Leuk Lymphoma. 2010 May;51(5):947-51. doi: 10.3109/10428191003699571.
4
Clonotypic B cells in classic Hodgkin lymphoma.经典型霍奇金淋巴瘤中的克隆型B细胞。
Blood. 2009 Oct 29;114(18):3970-1; author reply 3971-2. doi: 10.1182/blood-2009-06-229583.
5
Successful use of full-dose dexamethasone, high-dose cytarabine, and cisplatin as part of initial therapy in non-hodgkin and hodgkin lymphoma with severe hepatic dysfunction.在伴有严重肝功能不全的非霍奇金淋巴瘤和霍奇金淋巴瘤初始治疗中,成功使用全剂量地塞米松、大剂量阿糖胞苷和顺铂作为初始治疗方案的一部分。
Clin Lymphoma Myeloma. 2009 Apr;9(2):167-70. doi: 10.3816/CLM.2009.n.039.
6
Severe jaundice, due to vanishing bile duct syndrome, as presenting symptom of Hodgkin's lymphoma, fully reversible after chemotherapy.严重黄疸,由胆管消失综合征引起,作为霍奇金淋巴瘤的首发症状,化疗后完全可逆。
Eur J Gastroenterol Hepatol. 2008 Feb;20(2):145-7. doi: 10.1097/MEG.0b013e3282b9e6c2.
7
Gemcitabine, vinorelbine, and pegylated liposomal doxorubicin (GVD), a salvage regimen in relapsed Hodgkin's lymphoma: CALGB 59804.吉西他滨、长春瑞滨和聚乙二醇化脂质体阿霉素(GVD),复发霍奇金淋巴瘤的挽救方案:癌症和白血病研究组B(CALGB)59804。
Ann Oncol. 2007 Jun;18(6):1071-9. doi: 10.1093/annonc/mdm090. Epub 2007 Apr 10.
8
Chromosomal breakpoints affecting immunoglobulin loci are recurrent in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma.影响免疫球蛋白基因座的染色体断点在经典型霍奇金淋巴瘤的霍奇金和里德-斯腾伯格细胞中反复出现。
Cancer Res. 2006 Nov 1;66(21):10332-8. doi: 10.1158/0008-5472.CAN-06-1992.
9
[Spontaneous resolution of vanishing bile duct syndrome in Hodgkin's lymphoma].[霍奇金淋巴瘤中消失胆管综合征的自发缓解]
Korean J Hepatol. 2005 Jun;11(2):164-8.
10
[Ductal regeneration in vanishing bile duct syndrome in Hodgkin's lymphoma].[霍奇金淋巴瘤中消失性胆管综合征的胆管再生]
Gastroenterol Hepatol. 2005 May;28(5):275-8. doi: 10.1157/13074061.

1例肝功能严重受损的霍奇金淋巴瘤患者,接受吉西他滨治疗后再行ABVD方案治疗,获得成功。

A case of Hodgkin's lymphoma with severely impaired liver function treated successfully with gemcitabine followed by ABVD.

作者信息

Chakraborty Rajshekhar, Mukkamalla Shiva Kumar Reddy, Gutzmore Garfield, Chan Hon Cheung

机构信息

Hospitalist Services, Essentia Health, Brainerd, MN, USA.

Department of Internal Medicine, Queens Hospital Center (Affiliated Icahn School of Medicine at Mount Sinai), Jamaica, NY, USA.

出版信息

J Blood Med. 2015 Mar 23;6:93-7. doi: 10.2147/JBM.S67664. eCollection 2015.

DOI:10.2147/JBM.S67664
PMID:25848330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4376300/
Abstract

Hodgkin's lymphoma (HL) originates from clonal B cells and is the most common malignancy in the second decade of life. Liver involvement is uncommon at presentation in patients with HL and there is a paucity of data for treatment of patients with severely impaired liver function. We present an unusual case of HL with severe hepatic impairment, splenomegaly and multiple chromosomal abnormalities that was treated initially with gemcitabine and steroids. Once liver function tests improved, six cycles of Adriamycin, bleomycin, vinblastine, and dacarbazine were administered. The patient remains in remission at 3.5 years of follow-up.

摘要

霍奇金淋巴瘤(HL)起源于克隆性B细胞,是第二个十年中最常见的恶性肿瘤。HL患者初诊时肝脏受累并不常见,且关于肝功能严重受损患者的治疗数据较少。我们报告了一例罕见的HL病例,该患者伴有严重肝功能损害、脾肿大和多种染色体异常,最初接受吉西他滨和类固醇治疗。一旦肝功能检查有所改善,便给予六个周期的阿霉素、博来霉素、长春花碱和达卡巴嗪治疗。随访3.5年,患者仍处于缓解期。